Growth Metrics

Globus Medical (GMED) Long-Term Deferred Tax (2016 - 2025)

Globus Medical's Long-Term Deferred Tax history spans 14 years, with the latest figure at $218.2 million for Q4 2025.

  • For Q4 2025, Long-Term Deferred Tax rose 131.65% year-over-year to $218.2 million; the TTM value through Dec 2025 reached $218.2 million, up 131.65%, while the annual FY2025 figure was $218.2 million, 131.65% up from the prior year.
  • Long-Term Deferred Tax reached $218.2 million in Q4 2025 per GMED's latest filing, down from $232.4 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $275.9 million in Q2 2025 to a low of $7.3 million in Q3 2023.
  • Average Long-Term Deferred Tax over 5 years is $67.6 million, with a median of $39.9 million recorded in 2022.
  • Peak YoY movement for Long-Term Deferred Tax: plummeted 83.64% in 2023, then surged 1416.0% in 2025.
  • A 5-year view of Long-Term Deferred Tax shows it stood at $24.5 million in 2021, then skyrocketed by 99.42% to $48.8 million in 2022, then plummeted by 78.12% to $10.7 million in 2023, then surged by 781.61% to $94.2 million in 2024, then soared by 131.65% to $218.2 million in 2025.
  • Per Business Quant, the three most recent readings for GMED's Long-Term Deferred Tax are $218.2 million (Q4 2025), $232.4 million (Q3 2025), and $275.9 million (Q2 2025).